Symbols / ELAB
ELAB Chart
About
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.46M |
| Enterprise Value | -3.98M | Income | -6.49M | Sales | 285.95K |
| Book/sh | 45.64 | Cash/sh | 46.31 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2 | IPO | — |
| P/E | 0.01 | Forward P/E | — | PEG | — |
| P/S | 5.10 | P/B | 0.03 | P/C | — |
| EV/EBITDA | 0.68 | EV/Sales | -13.91 | Quick Ratio | 1.65 |
| Current Ratio | 1.79 | Debt/Eq | 51.93 | LT Debt/Eq | — |
| EPS (ttm) | 151.07 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -45.80% | Earnings | — | ROA | -27.98% |
| ROE | -76.20% | ROIC | — | Gross Margin | -82.03% |
| Oper. Margin | -7.52% | Profit Margin | 0.00% | Shs Outstand | 1.19M |
| Shs Float | 185.06K | Short Float | 2.59% | Short Ratio | 0.04 |
| Short Interest | — | 52W High | 164.07 | 52W Low | 1.15 |
| Beta | 0.70 | Avg Volume | 1.29M | Volume | 150.72K |
| Target Price | — | Recom | None | Prev Close | $1.21 |
| Price | $1.23 | Change | 1.65% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.23
Latest analyst target
3. DCF / Fair value
$-54.43
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.23
Low
—
High
—
Mean
—
- PMGC buys Silicon Valley maker of parts for robots and satellites - Stock Titan ue, 03 Feb 2026 08
- ELAB Stock Price, Forecast & Analysis | PMGC HOLDINGS INC (NASDAQ:ELAB) - ChartMill Fri, 20 Feb 2026 08
- Why Did ELAB Stock Surge Nearly 8% After-Hours Today? - Stocktwits Wed, 07 Jan 2026 08
- PMGC Holdings stock soars after filing 10 new patent applications By Investing.com - Investing.com South Africa hu, 19 Feb 2026 14
- ELAB Expands Manufacturing Footprint with Latest Acquisition - timothysykes.com hu, 19 Feb 2026 16
- Biotech bet on meat: new animal supplements seek more muscle, fewer emissions - Stock Titan hu, 19 Feb 2026 12
- PMGC Expands EL-22, EL-32 Tech Into Animal Health - TipRanks hu, 19 Feb 2026 15
- What's Going On With PMGC Holdings Stock Thursday? - Benzinga hu, 05 Feb 2026 08
- PMGC Holdings Inc Says Offering $1.2 Mln In Common Stock To Streeterville Capital - TradingView ue, 17 Feb 2026 23
- ELAB stock soars pre-market as PMGC subsidiary NorthStrive signs exclusive license agreement with Modulant Biosciences - MSN Mon, 16 Feb 2026 09
- ELAB Stock: Will The Surge Continue? - StocksToTrade ue, 14 Oct 2025 07
- PMGC Holdings Announces 1-for-4 Reverse Stock Split - The Globe and Mail Wed, 07 Jan 2026 08
- PMGC Stock Falls After Strategic Nuclear Investment Announcement - Nasdaq ue, 06 Jan 2026 08
- Why one company is shrinking its share count with a 1-for-4 stock split - Stock Titan Fri, 02 Jan 2026 08
- New AI models push NorthStrive drug study results into Q2 2026 - Stock Titan Wed, 04 Feb 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -3.63M | -1.12M | -1.77M | -782.30K |
| TotalUnusualItems | 363.31K | -527.48K | -17.05K | 323.00 |
| TotalUnusualItemsExcludingGoodwill | 363.31K | -527.48K | -17.05K | 323.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -4.02M | -1.66M | -1.80M | -784.74K |
| ReconciledDepreciation | 12.95K | 11.65K | 6.51K | 2.76K |
| ReconciledCostOfRevenue | 576.66K | 317.49K | 88.00 | |
| EBITDA | -3.27M | -1.65M | -1.79M | -781.98K |
| EBIT | -3.28M | -1.66M | -1.80M | -784.74K |
| NetInterestIncome | -722.31K | 5.56K | 5.07K | 0.00 |
| InterestExpense | 735.20K | 0.00 | 2.63K | 0.00 |
| InterestIncome | 12.89K | 5.56K | 7.70K | 0.00 |
| NormalizedIncome | -4.38M | -1.13M | -1.78M | -785.06K |
| NetIncomeFromContinuingAndDiscontinuedOperation | -6.25M | -4.30M | -1.80M | -784.74K |
| TotalExpenses | 3.66M | 1.13M | 2.55M | 785.89K |
| RentExpenseSupplemental | 126.10K | 73.36K | ||
| DilutedAverageShares | 5.68K | 884.00 | 884.00 | 884.00 |
| BasicAverageShares | 5.68K | 884.00 | 884.00 | 884.00 |
| DilutedEPS | -1.10K | -4.87K | -2.04K | -887.71 |
| BasicEPS | -1.10K | -4.87K | -2.04K | -887.71 |
| DilutedNIAvailtoComStockholders | -6.25M | -4.30M | -1.80M | -784.74K |
| NetIncomeCommonStockholders | -6.25M | -4.30M | -1.80M | -784.74K |
| NetIncome | -6.25M | -4.30M | -1.80M | -784.74K |
| NetIncomeIncludingNoncontrollingInterests | -6.25M | -4.30M | -1.80M | -784.74K |
| NetIncomeDiscontinuousOperations | -2.23M | -2.64M | ||
| NetIncomeContinuousOperations | -4.02M | -1.66M | -1.80M | -784.74K |
| PretaxIncome | -4.02M | -1.66M | -1.80M | -784.74K |
| OtherIncomeExpense | 363.31K | -527.48K | -17.05K | 323.00 |
| SpecialIncomeCharges | 0.00 | -450.08K | -1.55K | 0.00 |
| GainOnSaleOfPPE | 0.00 | -1.55K | 0.00 | |
| OtherSpecialCharges | 450.08K | |||
| GainOnSaleOfSecurity | 363.31K | -77.40K | -15.50K | 323.00 |
| NetNonOperatingInterestIncomeExpense | -722.31K | 5.56K | 5.07K | 0.00 |
| InterestExpenseNonOperating | 735.20K | 0.00 | 2.63K | 0.00 |
| InterestIncomeNonOperating | 12.89K | 5.56K | 7.70K | 0.00 |
| OperatingIncome | -3.66M | -1.13M | -1.79M | -785.06K |
| OperatingExpense | 3.66M | 1.13M | 2.24M | 785.80K |
| OtherOperatingExpenses | 236.91K | 110.39K | 272.44K | 25.45K |
| DepreciationAmortizationDepletionIncomeStatement | 546.00 | 554.00 | 5.03K | 2.38K |
| DepreciationAndAmortizationInIncomeStatement | 546.00 | 554.00 | 5.03K | 2.38K |
| DepreciationIncomeStatement | 546.00 | 554.00 | 5.03K | 2.38K |
| ResearchAndDevelopment | 104.65K | 7.41K | 228.75K | 123.63K |
| SellingGeneralAndAdministration | 3.32M | 1.02M | 1.73M | 634.33K |
| SellingAndMarketingExpense | 292.52K | 256.45K | 192.86K | 31.61K |
| GeneralAndAdministrativeExpense | 3.02M | 760.02K | 1.54M | 602.73K |
| OtherGandA | 2.86M | 760.02K | 680.82K | 602.73K |
| RentAndLandingFees | 126.10K | 73.36K | ||
| SalariesAndWages | 165.00K | 1.86M | 782.33K | |
| GrossProfit | 1.13M | 447.31K | 739.00 | |
| CostOfRevenue | 578.01K | 318.97K | 88.00 | |
| TotalRevenue | 0.00 | 0.00 | 766.28K | 827.00 |
| OperatingRevenue | 0.00 | 0.00 | 766.28K | 827.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 31.36K | 884.00 | 884.00 | 884.00 |
| ShareIssued | 31.36K | 884.00 | 884.00 | 884.00 |
| TotalDebt | 210.49K | 283.22K | 0.00 | |
| TangibleBookValue | 3.86M | 3.83M | 1.13M | 450.24K |
| InvestedCapital | 6.66M | 3.83M | 1.13M | 450.24K |
| WorkingCapital | 4.25M | 3.62M | 963.05K | 420.90K |
| NetTangibleAssets | 3.86M | 3.83M | 1.13M | 450.63K |
| CapitalLeaseObligations | 210.49K | 283.22K | 0.00 | |
| CommonStockEquity | 6.66M | 3.83M | 1.13M | 450.24K |
| PreferredStockEquity | 571.00 | 385.00 | ||
| TotalCapitalization | 6.66M | 3.83M | 1.13M | 450.63K |
| TotalEquityGrossMinorityInterest | 6.66M | 3.83M | 1.13M | 450.63K |
| StockholdersEquity | 6.66M | 3.83M | 1.13M | 450.63K |
| GainsLossesNotAffectingRetainedEarnings | -337.00 | 202.00 | 111.00 | 202.00 |
| OtherEquityAdjustments | -337.00 | 202.00 | 111.00 | 202.00 |
| RetainedEarnings | -13.27M | -7.02M | -2.72M | -922.11K |
| AdditionalPaidInCapital | 19.93M | 10.85M | 3.85M | 1.37M |
| CapitalStock | 44.00 | 1.00 | 1.53K | 1.34K |
| CommonStock | 44.00 | 1.00 | 957.00 | 952.00 |
| PreferredStock | 0.00 | 571.00 | 385.00 | |
| TotalLiabilitiesNetMinorityInterest | 2.33M | 1.36M | 760.87K | 215.62K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 534.47K | 65.49K | 172.60K | 0.00 |
| LiabilitiesHeldforSaleNonCurrent | 0.00 | 65.49K | ||
| TradeandOtherPayablesNonCurrent | 534.47K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 65.49K | 172.60K | 0.00 | |
| LongTermCapitalLeaseObligation | 65.49K | 172.60K | 0.00 | |
| CurrentLiabilities | 1.80M | 1.30M | 588.27K | 215.62K |
| OtherCurrentLiabilities | 548.92K | 1.09M | 68.45K | |
| CurrentDeferredLiabilities | 36.69K | 10.17K | 0.00 | |
| CurrentDeferredRevenue | 36.69K | 10.17K | 0.00 | |
| CurrentDebtAndCapitalLeaseObligation | 145.00K | 110.62K | ||
| CurrentCapitalLeaseObligation | 145.00K | 110.62K | 0.00 | |
| PayablesAndAccruedExpenses | 1.25M | 211.14K | 399.03K | 215.62K |
| CurrentAccruedExpenses | 73.23K | 33.86K | 93.93K | |
| Payables | 1.25M | 211.14K | 365.17K | 121.69K |
| OtherPayable | 350.00K | |||
| DuetoRelatedPartiesCurrent | 419.22K | 77.13K | 154.32K | 23.52K |
| AccountsPayable | 481.00K | 134.01K | 210.84K | 98.17K |
| TotalAssets | 8.99M | 5.19M | 1.89M | 666.25K |
| TotalNonCurrentAssets | 2.94M | 270.47K | 340.86K | 29.73K |
| OtherNonCurrentAssets | 268.73K | |||
| NonCurrentPrepaidAssets | 10.77K | 10.77K | ||
| InvestmentsAndAdvances | 139.08K | 0.00 | ||
| InvestmentinFinancialAssets | 139.08K | 0.00 | ||
| AvailableForSaleSecurities | 139.08K | |||
| TradingSecurities | 139.08K | 0.00 | ||
| GoodwillAndOtherIntangibleAssets | 2.80M | 0.00 | ||
| OtherIntangibleAssets | 2.80M | |||
| NetPPE | 1.09K | 1.74K | 330.09K | 29.73K |
| AccumulatedDepreciation | -1.51K | -1.08K | -8.11K | -2.76K |
| GrossPPE | 2.60K | 2.82K | 338.19K | 32.48K |
| OtherProperties | 259.76K | 327.07K | 32.48K | |
| MachineryFurnitureEquipment | 2.60K | 2.82K | 11.12K | 0.00 |
| CurrentAssets | 6.05M | 4.92M | 1.55M | 636.52K |
| AssetsHeldForSaleCurrent | 1.19M | 687.47K | ||
| PrepaidAssets | 868.46K | 902.05K | 153.42K | 62.14K |
| Inventory | 495.67K | 230.15K | 160.82K | |
| FinishedGoods | 68.25K | 32.03K | 48.68K | |
| WorkInProcess | 147.91K | 116.98K | 28.12K | |
| RawMaterials | 279.51K | 81.13K | 84.02K | |
| Receivables | 5.28K | 3.07K | 12.85K | 1.71K |
| TaxesReceivable | 5.28K | 3.07K | 8.67K | 1.71K |
| AccountsReceivable | 33.09K | 4.18K | 0.00 | |
| CashCashEquivalentsAndShortTermInvestments | 3.98M | 3.33M | 1.15M | 411.86K |
| CashAndCashEquivalents | 3.98M | 3.33M | 1.15M | 411.86K |
| CashFinancial | 3.98M | 3.33M | 1.15M | 411.86K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.96M | -4.57M | -1.62M | -693.42K |
| RepaymentOfDebt | -1.15M | 0.00 | ||
| IssuanceOfDebt | 914.44K | 0.00 | 183.97K | 0.00 |
| IssuanceOfCapitalStock | 6.99M | 6.70M | 2.15M | 1.09M |
| CapitalExpenditure | -471.48K | -11.19K | -35.53K | -32.48K |
| InterestPaidSupplementalData | 69.03K | 14.40K | 0.00 | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 3.98M | 3.33M | 1.15M | 411.86K |
| BeginningCashPosition | 3.33M | 1.15M | 411.86K | 13.35K |
| EffectOfExchangeRateChanges | -2.35K | 1.06K | -1.31K | 1.35K |
| ChangesInCash | 659.96K | 2.17M | 744.36K | 397.16K |
| FinancingCashFlow | 6.76M | 6.74M | 2.36M | 1.09M |
| CashFlowFromContinuingFinancingActivities | 6.76M | 6.74M | 2.36M | 1.09M |
| NetOtherFinancingCharges | -762.20K | |||
| ProceedsFromStockOptionExercised | 0.00 | 37.50K | 25.00K | 0.00 |
| NetPreferredStockIssuance | 0.00 | 2.15M | 1.09M | |
| PreferredStockIssuance | 0.00 | 2.15M | 1.09M | |
| NetCommonStockIssuance | 6.99M | 6.70M | 0.00 | |
| CommonStockIssuance | 6.99M | 6.70M | 0.00 | |
| NetIssuancePaymentsOfDebt | -235.56K | 0.00 | 183.97K | 0.00 |
| NetShortTermDebtIssuance | 0.00 | 183.97K | 0.00 | |
| ShortTermDebtIssuance | 0.00 | 183.97K | 0.00 | |
| NetLongTermDebtIssuance | -235.56K | 0.00 | ||
| LongTermDebtPayments | -1.15M | 0.00 | ||
| LongTermDebtIssuance | 914.44K | 0.00 | ||
| InvestingCashFlow | -610.56K | -11.19K | -32.03K | -32.48K |
| CashFlowFromContinuingInvestingActivities | -610.56K | -11.19K | -32.03K | -32.48K |
| NetInvestmentPurchaseAndSale | -139.08K | 0.00 | ||
| PurchaseOfInvestment | -139.08K | 0.00 | ||
| NetIntangiblesPurchaseAndSale | -462.32K | 0.00 | ||
| PurchaseOfIntangibles | -462.32K | 0.00 | ||
| NetPPEPurchaseAndSale | -9.16K | -11.19K | -32.03K | -32.48K |
| SaleOfPPE | 0.00 | 3.50K | ||
| PurchaseOfPPE | -9.16K | -11.19K | -35.53K | -32.48K |
| OperatingCashFlow | -5.49M | -4.56M | -1.59M | -660.93K |
| CashFlowFromContinuingOperatingActivities | -5.49M | -4.56M | -1.59M | -660.93K |
| ChangeInWorkingCapital | 251.67K | -823.19K | 12.43K | -21.91K |
| ChangeInOtherWorkingCapital | -2.39K | 26.52K | 10.17K | |
| ChangeInPayablesAndAccruedExpense | 605.23K | 346.37K | 185.19K | 199.10K |
| ChangeInPayable | 605.23K | 346.37K | 185.19K | 199.10K |
| ChangeInAccountPayable | 207.50K | 466.89K | 65.19K | 192.09K |
| ChangeInPrepaidAssets | 65.10K | -907.34K | -102.06K | -58.84K |
| ChangeInInventory | -403.30K | -265.52K | -69.33K | -160.82K |
| ChangeInReceivables | -12.97K | -23.22K | -11.55K | -1.35K |
| OtherNonCashItems | 766.13K | -2.76K | 9.28K | 600.00 |
| StockBasedCompensation | 97.17K | 487.74K | 171.87K | 142.35K |
| DepreciationAmortizationDepletion | 12.95K | 11.65K | 6.51K | 2.76K |
| DepreciationAndAmortization | 12.95K | 11.65K | 6.51K | 2.76K |
| Depreciation | 12.95K | 11.65K | 6.51K | 2.76K |
| OperatingGainsLosses | -369.16K | 71.27K | 14.30K | |
| GainLossOnInvestmentSecurities | -369.16K | 71.27K | 12.75K | |
| GainLossOnSaleOfPPE | 0.00 | 1.55K | 0.00 | |
| NetIncomeFromContinuingOperations | -6.25M | -4.30M | -1.80M | -784.74K |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ELAB
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|